N. P. Taşlı Et Al. , "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.," FRONTIERS IN IMMUNOLOGY , vol.13, pp.1-15, 2022
Taşlı, N. P. Et Al. 2022. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.. FRONTIERS IN IMMUNOLOGY , vol.13 , 1-15.
Taşlı, N. P., Gönen, Z. B., Kırbaş, O. K., Gökdemir, N. S., Bozkurt, B. T., Bayrakçı, B., ... Sağraç, D.(2022). Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.. FRONTIERS IN IMMUNOLOGY , vol.13, 1-15.
Taşlı, Neslihan Et Al. "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.," FRONTIERS IN IMMUNOLOGY , vol.13, 1-15, 2022
Taşlı, Neslihan P. Et Al. "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.." FRONTIERS IN IMMUNOLOGY , vol.13, pp.1-15, 2022
Taşlı, N. P. Et Al. (2022) . "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.." FRONTIERS IN IMMUNOLOGY , vol.13, pp.1-15.
@article{article, author={Neslihan Pakize Taşlı Et Al. }, title={Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.}, journal={FRONTIERS IN IMMUNOLOGY}, year=2022, pages={1-15} }